Max Darer, Lowes Financial Management, 24/04/2024
Walker Crips have recently released a duo of capital at risk autocalls linked to the Nikkei 225. These mark the first plans to be linked to the Japanese blue chip index in the UK retail sector since 2015 which were FOCUS plans linked to the Nikkei and Euro Stoxx 50. We have to go back to 2007 to see a structured product linked solely to the Nikkei 225 where Abbey Capital had a range of Guaranteed Japanese Equity Bonds. These provided capped upside returns but did not subject investors to risk of loss through their deposit-based structure however, none of these provided a gain at maturity.
The latest Nikkei linked autocalls come in the form of a 6-year at-the-money, offering 10.75% for each year held and a step-down contract requiring the index to be above 85% of the strike level after 6 years in return for 9% p.a. Both plans have 50% end of term barriers and have Morgan Stanley & Co. International as counterparty.
We are acutely aware that the Nikkei has shown significant growth of late and acknowledge that this could continue. Equally, we know this to be one of the more volatile indices and whilst the deep protection barrier of 50% observed only at the end of the maximum term, and then only if the plan hasn’t matured sooner, will afford some comfort, we feel that the additional potential coupon offered over a FTSE only contract may not be sufficient to attract investors.
Looking at historical backtesting since 1965 on the Nikkei for the latest step-down contract we can see the total number of maturity outcomes that would have occurred historically from the more than 14,000 possible start dates.
Year |
No. of kickouts |
% |
|
Opportunity 1 |
2 |
9,788 |
69.86% |
Opportunity 2 |
3 |
1,082 |
7.72% |
Opportunity 3 |
4 |
527 |
3.76% |
Opportunity 4 |
5 |
434 |
3.10% |
Opportunity 5 |
6 |
350 |
2.50% |
Returned capital only |
1,490 |
10.64% |
|
Returned loss |
329 |
2.35% |
|
Yet to kick out, post 1st opportunity |
10 |
0.07% |
|
Total |
14,010 |
100% |
Source StructuredProductReview.com, Yahoo Finance
The structure would have disappointed for almost 13% of all possible observations (these theoretical strike dates shown as blue and red above) albeit with only 2.35% (red) resulting in a capital loss, which by definition would have been at least 50%. Whilst the remaining 86.95% of the time a positive return would have arisen, with the index at its current high the question remains, is a 9% coupon on this contract enough of an uplift from a standard FTSE only autocall for the increased risk that a positive return may not result?
Structured investments put capital at risk.
Past performance is not indicative of future results.
Also in this section
- How old is too old? Are structured products to die for?
- Product focus - October 2024
- Q3 2024 Issuance
- Q3 2024 maturity results
- A share of spread bets on steroids?
- Product focus - September 2024
- Maturities of the month - August 2024
- Right on time
- Product focus - August 2024
- Keep calm and zoom out
- 2,000 and counting
- Q2 2024 maturity results
- 20 years of autocall maturities
- Product focus - June 2024
- Fixed income or interest?
- Maturities of the month - May 2024
- The barrier debate - revisited
- Product focus - April 2024
- Maturities of the month - April 2024
- Time to call
- I don't believe markets are ever too high for Structured products!
- Notes on counterparty exposure
- Return of Nikkei
- Q1 2024 issuance
- Q1 2024 maturity results
- Structured Products – AAAAAGH!
- Hop in CIBC
- Re-enter Santander
- How to build a financial fortune - revisited
- Issuance in 2023
- Where's the risk?
- Questionable offerings
- Challenging the case against structured products - 'Loss of dividends'
- Navigating the investment landscape
- Challenging the case against structured products - Counterparty risk
- 6-year autocalls approaching final destination
- 1,750 FTSE capital at risk autocall maturities
- The leopard that changed her spots
- Q3 2023
- Challenging the case against structured products - Keydata
- Dilemmas for UK IFA's and the unique role of Structured Products
- 'High charges'
- Precipice bonds
- Intro
- FTSE 100 Contingent Income
- Indexing the indices
- Something different
- Investing through volatility
- 100 10:10s
- The best or worst?
- The 10%/25% 'Rule' that never was
- Structured products and the yield curve
- Fixed income: Capital at risk?
- Prospects for UK inflation - and fun with A.I!
- The Barrier Debate
- More Deposits for now
- Last of the Americans
- What if?
- Time heals all wounds, we hope...
- How to diversify portfolios using structured products?
- The Proof Is In The Pudding...
- Debunking Structured Misconceptions
- 1,500 FTSE Capital-at-Risk Autocall Maturities
- Q3 2022 Maturity Results
- What do we prefer?
- Deposits vs Capital ‘Protected’
- There’s time yet…
- Where did you invest your clients?
- A Six-Month Reflection
- Return of the Rev Con
- Happy 2nd Birthday FTSE CSDI
- Q2 2022 Maturity Results
- The best and worst yet still the best
- Critique my Suitability - Mariana 10:10 Plan June 2022 (Option 2)
- 10/10 for 55 10:10’s
- Q1 2022 Maturity Results
- 'How to build a financial fortune': a follow up
- Critique my Suitability - Mariana 10:10 Plan April 2022 (Option 2)
- 2021 Capital-at-Risk Autocall Maturity Review
- An unwelcome return...
- CSDI's First Birthday
- Bon Anniversaire
- Introducing the FTSE Custom 100 Synthetic 3.5% Fixed Dividend Index
- Q3 2021 Maturity Results
- Critique my Suitability - Mariana 10:10 Plan October 2021 (Option 2)
- Blurring the lines...
- Beware of false knowledge; it is more dangerous than ignorance
- Good news, bad news...
- Certainty is Certainly a Benefit
- Critique my Suitability - Mariana 10:10 Plan September 2021 (Option 2)
- A Twenty-Year Progression
- Q2 2021 Maturity Results
- Nine 8:8s Post Positive Returns in Falling Markets
- Critique my Suitability
- Q1 2021 Maturity Results
- Morgan Stanley’s Marvelous Maturity Medley
Current Products
We review the UK's retail structured investment sector, providing pertinent support for Professional Advisers and relevant research tools.
View all ⟶